Orchard Hill, Supernus Pharmaceuticals: Earlier this year, Orchard Hill Capital Management purchased a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) which contained 3.5 million shares, a new filing with the SEC stated. Orchard Hill holds 10.2% of the company.
Recommended Reading:
Mason Hawkins, Southeastern Asset Management Up Stake in Guinness Peat
4 Videos of Warren Buffett on Piers Morgan That Will Make Your Morning
